Cargando…
Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment
Drug resistance represents the major obstacle to get the maximum therapeutic benefit for patients with esophageal cancer since numerous patients are inherently or adaptively resistant to therapeutic agents. Notably, increasing evidence has demonstrated that drug resistance is closely related to the...
Autores principales: | Luan, Siyuan, Zeng, Xiaoxi, Zhang, Chao, Qiu, Jiajun, Yang, Yushang, Mao, Chengyi, Xiao, Xin, Zhou, Jianfeng, Zhang, Yonggang, Yuan, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017339/ https://www.ncbi.nlm.nih.gov/pubmed/33816512 http://dx.doi.org/10.3389/fcell.2021.664816 |
Ejemplares similares
-
Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer
por: Mao, Chengyi, et al.
Publicado: (2021) -
Gut Microbiota for Esophageal Cancer: Role in Carcinogenesis and Clinical Implications
por: Zhou, Jianfeng, et al.
Publicado: (2021) -
Targeting the Microenvironment in Esophageal Cancer
por: Wang, Lei, et al.
Publicado: (2021) -
Editorial: Tumor microenvironment (TME) and tumor immune microenvironment (TIME): New perspectives for prognosis and therapy
por: Ramos, Rodrigo Nalio, et al.
Publicado: (2022) -
Stratification From Heterogeneity of the Cell-Death Signal Enables Prognosis Prediction and Immune Microenvironment Characterization in Esophageal Squamous Cell Carcinoma
por: Zhang, Yiyuan, et al.
Publicado: (2022)